Off-label use of drugs in pediatric (specialized) outpatient clinics-What has changed between 2009 and 2019?

Toni I, Hupfer J, Gerber C, Rascher W, Neubert A (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Pharmacoepidemiology and Drug Safety Wiley-Blackwell

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 469-469

Conference Proceedings Title: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

DOI: 10.1136/archdischild-2023-esdppp.33

Authors with CRIS profile

Irmgard Toni Department of Paediatrics and Adolescent Medicine Jutta Hupfer Department of Paediatrics and Adolescent Medicine Christine Gerber Department of Paediatrics and Adolescent Medicine Wolfgang Rascher Department of Paediatrics and Adolescent Medicine Antje Neubert Department of Paediatrics and Adolescent Medicine

How to cite

APA:

Toni, I., Hupfer, J., Gerber, C., Rascher, W., & Neubert, A. (2022). Off-label use of drugs in pediatric (specialized) outpatient clinics-What has changed between 2009 and 2019? In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (pp. 469-469). HOBOKEN: WILEY.

MLA:

Toni, Irmgard, et al. "Off-label use of drugs in pediatric (specialized) outpatient clinics-What has changed between 2009 and 2019?" Proceedings of the PHARMACOEPIDEMIOLOGY AND DRUG SAFETY HOBOKEN: WILEY, 2022. 469-469.

BibTeX: Download